Szarpak Łukasz, Kurowski Andrzej, Czyżewski Łukasz, Madziała Marcin, Truszewski Zenon
Department of Emergency Medicine, Medical University of Warsaw, Warsaw, Poland.
Department of Anesthesiology, Cardinal Wyszynski National Institute of Cardiology, Warsaw, Poland.
Am J Emerg Med. 2015 Jul;33(7):872-5. doi: 10.1016/j.ajem.2015.02.018. Epub 2015 Feb 19.
The aim of the study was to compare the efficacy of the TruView EVO2, TruView PCD, and Miller laryngoscopes for tracheal intubation during cardiopulmonary resuscitation with and without chest compressions (CCs) by paramedics in an infant manikin model.
This was an open, prospective, randomized, simulated trial. After a brief didactic session, 78 volunteer paramedics attempted to intubate a manikin using TruView EVO2, TruView PCD, and Miller laryngoscopes during resuscitation with and without CC scenarios. Primary end point was intubation success rate and secondary was time to intubation with each device. Glottic view using a Cormack-Lehane grade in using each device was also assessed.
In scenario with uninterrupted CCs, the median time to intubation using the TruView EVO2, TruView PCD, and Miller varied with the times being 25.3 seconds (interquartile range [IQR], 23-30.5 seconds) vs 20.2 seconds (IQR, 18-23 seconds) vs 24.4 seconds (IQR, 21-28 seconds), respectively. The overall success rate of intubation during CC for the devices were 94.9% vs 100% vs 92.1%. During intubation without CC, median time to intubation varied and amounted to 24.9 seconds (IQR, 21-29.6 seconds) for TruView EVO2, 18.3 seconds (IQR, 16-21.3 seconds) for TruView PCD, and 19.4 seconds (IQR, 17-23.3 seconds) for Miller laryngoscope. The overall success rate of intubation without CC for all devices was 100%.
For infant tracheal intubation with TruView PCD, when used by paramedics, the malleable TruView PCD showed shorter intubation time and higher overall success rate in a simulated CC scenario than TruView EVO2 or Miller laryngoscopes. Further clinical studies are necessary to confirm these initial positive findings.
本研究的目的是在婴儿人体模型中,比较护理人员在有和没有胸外按压(CCs)的心肺复苏期间,使用TruView EVO2喉镜、TruView PCD喉镜和米勒喉镜进行气管插管的效果。
这是一项开放、前瞻性、随机模拟试验。在简短的教学课程后,78名志愿护理人员在有和没有CCs的复苏场景中,尝试使用TruView EVO2喉镜、TruView PCD喉镜和米勒喉镜对人体模型进行插管。主要终点是插管成功率,次要终点是每种设备的插管时间。还评估了使用每种设备时根据Cormack-Lehane分级的声门视野。
在持续胸外按压的场景中,使用TruView EVO2喉镜、TruView PCD喉镜和米勒喉镜的插管中位时间各不相同,分别为25.3秒(四分位间距[IQR],23 - 30.5秒)、20.2秒(IQR,18 - 23秒)和24.4秒(IQR,21 - 28秒)。在胸外按压期间,这些设备的总体插管成功率分别为94.9%、100%和92.1%。在没有胸外按压的插管过程中,插管中位时间也各不相同,TruView EVO2喉镜为24.9秒(IQR,21 - 29.6秒),TruView PCD喉镜为18.3秒(IQR,16 - 21.3秒),米勒喉镜为19.4秒(IQR,17 - 23.3秒)。所有设备在没有胸外按压时的总体插管成功率为100%。
对于护理人员使用TruView PCD喉镜进行婴儿气管插管,在模拟胸外按压场景中,可塑形的TruView PCD喉镜比TruView EVO2喉镜或米勒喉镜显示出更短的插管时间和更高的总体成功率。需要进一步的临床研究来证实这些初步的阳性发现。